Cefiderocol Resistance Conferred by Plasmid-Located Ferric Citrate Transport System in KPC-Producing Klebsiella pneumoniae
Cefiderocol (FDC), a siderophore-cephalosporin conjugate, is the newest option for treating infection with carbapenem-resistant gram-negative bacteria. We identified a novel mechanism contributing to decreased FDC susceptibility in Klebsiella pneumoniae clinical isolates. The mechanism involves 2 c...
Saved in:
Main Authors: | Riccardo Polani, Alice De Francesco, Dario Tomolillo, Irene Artuso, Michele Equestre, Rita Trirocco, Gabriele Arcari, Guido Antonelli, Laura Villa, Gianni Prosseda, Paolo Visca, Alessandra Carattoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2025-01-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/31/1/24-1426_article |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emergence of cefiderocol resistance during therapy in NDM-5–producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations
by: Luc Deroche, et al.
Published: (2025-02-01) -
Sensitivity profile of carbapenem-resistant uropathogenic bacterial isolates to Cefiderocol
by: Fatemeh Omidi, et al.
Published: (2024-10-01) -
In vitro mimicry of in vivo KPC mutations by ceftazidime-avibactam: phenotypes, mechanisms, genetic structure and kinetics of enzymatic hydrolysis
by: Siquan Shen, et al.
Published: (2024-12-01) -
Cefiderocol in the Successful Treatment of Complicated Hospital-Acquired K. pneumoniae NDM, OXA48 Intraabdominal Infection
by: Tarski I, et al.
Published: (2024-11-01) -
A Novel Variant of KPC-179 Conferring Ceftazidime-Avibactam Resistance in a Carbapenem-Resistant Klebsiella pneumoniae Isolate
by: Liao Q, et al.
Published: (2024-11-01)